블로그
- CNN10 ️ 260112 ️ The discovery that could shed light on the origin of "dark matter" | 영어뉴스스터디 light on the origin of "dark matter" We'll take a look at protests in major cities across the U.S. after Plus, we'll get a look at a discovery that scientists say could .......
- 2026.7.29 - China Shock Just Came for Your Portfolio Plus, the Fed keeps us guessing. Given recent AI angst, Microsoft and Meta earnings after.......
- 2026.7.24 - Plus, there’s a new tariff in town By Spencer Jakab 1 hour ago While you were sleeping, President Trump After Thursday’s tech wipeout, stock futures suggest a modest rebound to end the week.
- 2026.6.25 - 마이크론, AI 수요에 실적·전망 예상 상회 / 중국 슈퍼컴퓨터 2위인 미 엘 카피탄 보다 22% 더 빠른 연산 속도 That’s after the stock fell 13% on Tuesday amid a selloff in AI-related companies. Its earnings report after the bel.......
- 2026.07.20 - SK 하이닉스 등의 장기 계약은 견고하지 않다 / 알리바바, 앤트로픽 페이블 5 이은 두 번째로 뛰어난 새 AI 모델 Qwen3.8-Max-Preview Plus, oil’s on the boil. But, after plenty of nervousness last week over fighting in the Middle East and the wobbly AI trade,
- 2026.7.11 - SK하이닉스, 나스닥 첫날 168.49달러 마감…공모가 대비 13%↑ / '통화스와프급' 달러 폭탄 퍼붓는 SK하이닉스 Huang and Jiyoung Sohn July 11, 2026 THE 10-POINT Washington’s Bet on Intel Is Starting to Pay Off Plus , Texas goes after Wall Street’s stock-exchange duopoly, and Apple alleges OpenAI stole trade secrets
- * ♬Abc(가사 첨부) / Michael Jackson * Jermaine: Like I before E except after C... Michael: And why 2 plus 2 makes four Now now now, I'm gonna teach you...
- oracle xe 8080 port change Google AI To change the Oracle XE 8080 port, you must use the DBMS_XDB.SETHTTPPORT command in SQL*Plus Connect to the database using SQL*Plus: SQLPLUS /NOLOG.
- 안팔레옹이 3대 격추되었다고...? 닥쳐 가짜뉴스 약팔이 병신 거짓말쟁이들아... 우린 다른 5,6세대 7세대 따위 전투기 닥치고 전쟁영웅 안팔레옹 114대 도입한다. 파트-01 https://www.opex360.com/2025/09/13/la-force-aerienne-indienne-recommande-dacquerir-114-rafale-de-plus-pour more Rafales for €18.7 billion by Laurent Lagneau · September 13, 2025Rafale Upgrade Kits In 2018, after
- Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer Background patients with hormone-receptor positive/HER2-negative metastatic breast cancer is CDK4/6 inhibitor plus
1 페이지
다음 →